Systematic search for gastric cancer-specific genes based on SAGE data: Melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer

Oncogene

Volumn 25, Issue 17, 2006, Pages 2546-2557

  Aung, P P ^a   Oue, N ^a   Mitani, Y ^a   Nakayama, H ^a   Yoshida, K ^b   Noguchi, T ^c   Bosserhoff, A K ^d   Yasui, W ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c OITA UNIVERSITY   (Japan)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

DKK4; Gastric cancer; MIA; MMP10; SAGE; Tumor serum marker

Indexed keywords

APIN; CYTOCHROME P450; DICKKOPF HOMOLOG 4 PROTEIN; HORMA DOMAIN CONTAINING 1 PROTEIN; MELANOMA INHIBITORY ACTIVITY PROTEIN; REGENERATING ISLET DERIVED FAMILY MEMBER 4 PROTEIN; STROMELYSIN 2; TAXOL RESISTANCE ASSOCIATED PROTEIN 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; APIN GENE; ARTICLE; CANCER DIAGNOSIS; CELL INVASION; CONTROLLED STUDY; CYP2W1 GENE; DIAGNOSTIC VALUE; DKK4 GENE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; GW112 GENE; HORMA GENE; HORMAD1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIA GENE; MMP 10 GENE; PRIORITY JOURNAL; PROGNOSIS; REGIV GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; STOMACH CANCER; TISSUE SPECIFICITY; TRAG3 GENE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 10; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646155334     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209279     Document Type: Article

References (51)

1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL et al. (1988). Cancer Res 48: 589-601.
2. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A et al. (2004). Cancer Res 64: 844-856.
3. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y et al. (1999). Am J Surg 178: 256-262.
4. Beachy PA, Karhadkar SS, Berman DM. (2004). Nature 432: 324-331.
5. Blesch A, Bosserhoff AK, Apfel R, Behl C, Hessdoerfer B, Schmitt A et al. (1994). Cancer Res 54: 5695-5701.
6. Bodey B, Bodey Jr B, Siegel SE, Kaiser HE. (2000). Anticancer Res 20: 4585-4590.
7. Bosserhoff AK, Echtenacher B, Hein R, Buettner R. (2001). Melanoma Res 11: 417-421.
8. Bosserhoff AK, Kaufmann M, Kaluza B, Bartke I, Zirngibl H, Hein R et al. (1997). Cancer Res 57: 3149-3153.
9. Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R. (1999). J Pathol 187: 446-454.
10. Buckhaults P, Rago C, St Croix B, Romans KE, Saha S, Zhang L et al. (2001). Cancer Res 61: 6996-7001.
11. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J et al. (2003). Genome Res 13: 2265-2270.
12. Dietz UH, Sandell LJ. (1996). J Biol Chem 271: 3311-3316.
13. El Fitori J, Kleeff J, Giese NA, Guweidhi A, Bosserhoff AK, Buchler MW et al. (2005). Cancer Cell Int 5: 3.
14. Hau P, Apfel R, Wiese P, Tschertner I, Blesch A, Bogdahn U. (2002). Anticancer Res 22: 577-583.
15. Hau P, Ruemmele P, Kunz-Schughart LA, Doerfelt A, Hirschmann B, Lohmeier A et al. (2004). Oncol Rep 12: 1355-1364.
16. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. (1995). Ann Rheum Dis 54: 25-32.
17. Hohenberger P, Gretschel S. (2003). Lancet 362: 305-315.
18. Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S et al. (2004). Arthritis Rheum 50: 131-141.
19. Koga T, Kano T, Souda K, Oka N, Inokuchi K. (1987). Jpn J Surg 17: 342-347.
20. Kondo T, Oue N, Yoshida K, Mitani Y, Naka K, Nakayama H et al. (2004). Cancer Res 64: 523-529.
21. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L et al. (1999). Gene 238: 301-313.
22. Lal A, Lash AE, Altschul SF, Velculescu V, Zhang L, McLendon RE et al. (1999). Cancer Res 59: 5403-5407.
23. Lauren P. (1965). Acta Pathol Microbiol Scand 64: 31-49.
24. Mantel N. (1966). Cancer Chemother Rep 50: 163-170.
25. Mao B, Niehrs C. (2003). Gene 302: 179-183.
26. Mathew R, Khanna R, Kumar R, Mathur M, Shukla NK, Ralhan R. (2002). Cancer Detect Prev 26: 222-228.
27. Molnar IG, Vandevoorde JP, Gitnick GL. (1976). Gastroenterology 70: 513-515.
28. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H et al. (1991). Int J Cancer 48: 550-556.
29. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. (1998). Eur J Biochem 253: 67-75.
30. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. (2000). J Clin Oncol 18: 1135-1149.
31. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. (1996). Int J Cancer 69: 9-16.
32. Ohgaki H, Matsukura N. (2003). Stomach cancer. In: Stewart BW, Kleihues P (eds). World Cancer Report. IARC Press: Lyon, p 197.
33. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP et al. (2004). Cancer Res 64: 2397-2405.
34. Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M et al. (2005). J Pathol 207: 185-198.
35. Poser I, Tatzel J, Kuphal S, Bosserhoff AK. (2004). Oncogene 23: 6115-6124.
36. Ramos MC, Steinbrenner H, Stuhlmann D, Sies H, Brenneisen P. (2004). Biol Chem 385: 75-86.
37. Rizvi NA, Humphrey JS, Ness EA, Johnson MD, Gupta E, Williams K et al. (2004). Clin Cancer Res 10: 1963-1970.
38. Rudek MA, Figg WD, Dyer V, Dahut W, Turner ML, Steinberg SM et al. (2001). J Clin Oncol 19: 584-592.
39. Saghizadeh M, Brown DJ, Castellon R, Chwa M, Huang GH, Ljubimova JY et al. (2001). Am J Pathol 158: 723-734.
40. Sharma R, Chattopadhyay TK, Mathur M, Ralhan R. (2004). Oncology 67: 300-309.
41. Shimizu N, Wakatsuki T, Murakami A, Yoshioka H, Hamazoe R, Kanayama H et al. (1987). Oncology 44: 240-244.
42. Sobin LH, Wittekind CH (ed). (2002). TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss, Inc.: New York, pp 65-68.
43. Solomon A, Murphy CL, Weaver K, Weiss DT, Hrncic R, Eulitz M et al. (2003). J Lab Clin Med 142: 348-355.
44. Thorns V, Walter GF, Thorns C. (2003). Anticancer Res 23: 3937-3944.
45. Ushijima T, Sasako M. (2004). Cancer Cell 5: 121-125.
46. Visse R, Nagase H. (2003). Circ Res 92: 827-839.
47. Yamashita K, Azumano I, Mai M, Okada Y. (1998). Int J Cancer 79: 187-194.
48. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. (2004). Cancer Sci 95: 385-392.
49. Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E. (2000). J Gastroenterol 35: 111-115.
50. Zhang X, Huang Q, Yang Z, Li Y, Li CY. (2004). Cancer Res 64: 2474-2481.
51. Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L et al. (1999). Ann N Y Acad Sci 878: 212-227.